CVS Health Company Insiders

CVS Stock  USD 79.43  0.11  0.14%   
Slightly above 70% of CVS Health's corporate insiders are selling. The analysis of insiders' sentiment of trading CVS Health Corp stock suggests that many insiders are alarmed at this time. CVS Health employs about 219 K people. The company is managed by 53 executives with a total tenure of roughly 367 years, averaging almost 6.0 years of service per executive, having 4132.08 employees per reported executive.
Larry Merlo  CEO
President, Chief Executive Officer, Director
David Dorman  Chairman
Independent Chairman of the Board

CVS Health's Insider Buying Vs Selling

30

 
Selling
 
Buying

Latest Trades

2024-02-16Prem S ShahDisposed 29473 @ 76.95View
2023-12-14Jerry MoranDisposed @ 74.5
2023-11-03Edward J LudwigAcquired 2000 @ 70.47View
2023-09-21Pete RickettsDisposed @ 71.91
2023-08-22Dan SullivanDisposed @ 67.05
2023-08-03James David ClarkDisposed 25759 @ 74.92View
2023-06-22Dwight EvansAcquired @ 69.41
2023-06-08William R. KeatingDisposed @ 71.74
2023-05-26Zoe LofgrenDisposed @ 67.64
2023-05-03Karen S LynchAcquired 14000 @ 69.75View
Monitoring CVS Health's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.

Acquired vs Disposed

Filed vs Not Filed

Insider sentiment refers to the collective sentiment or feeling of CVS Health's insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of CVS Health Corp. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe CVS Health's stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

CVS Health's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with CVS Health's future performance. Based on our forecasts, it is anticipated that CVS will maintain a workforce of slightly above 219000 employees by April 2024.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

CVS Health's latest congressional trading

Congressional trading in companies like CVS Health Corp, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in CVS Health by those in governmental positions are based on the same information available to the general public.
2023-09-21Senator John P RickettsAcquired $50K to $100KVerify
2023-06-22Representative Dwight EvansAcquired Under $15KVerify
2023-01-11Senator Thomas R. CarperAcquired Under $15KVerify
2022-02-28Representative Donald S. Beyer, Jr.Disposed Under $15KVerify
2021-12-21Senator Jerry MoranAcquired Under $15KVerify
2021-10-28Representative Kim SchrierDisposed $15K to $50KVerify
2021-09-27Representative Earl BlumenauerAcquired $15K to $50KVerify
2021-03-01Representative Michael T. McCaulAcquired $50K to $100KVerify
2020-11-05Senator Bill CassidyAcquired Under $15KVerify
2020-09-16Representative Gilbert CisnerosDisposed Under $15KVerify
2020-07-28Representative Carol Devine MillerDisposed $15K to $50KVerify
2020-04-14Senator Kelly LoefflerAcquired $250K to $500KVerify
2020-01-02Representative Mo BrooksDisposed Under $15KVerify
2019-08-27Senator Sheldon WhitehouseAcquired Under $15KVerify
2019-05-08Representative Bill FloresAcquired Under $15KVerify
2019-04-11Representative Brian MastAcquired $50K to $100KVerify
2019-02-28Senator Jack ReedAcquired Under $15KVerify
2018-12-27Representative Steve CohenDisposed $15K to $50KVerify
2017-10-25Senator William CassidyAcquired Under $15KVerify
2017-05-24Senator Susan M. CollinsAcquired $15K to $50KVerify

CVS Health Management Team Effectiveness

The company has Return on Asset of 0.0368 % which means that on every $100 spent on assets, it made $0.0368 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1128 %, implying that it generated $0.1128 on every 100 dollars invested. CVS Health's management efficiency ratios could be used to measure how well CVS Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, CVS Health's Return On Assets are comparatively stable compared to the past year. Return On Equity is likely to gain to 0.12 in 2024, whereas Return On Capital Employed is likely to drop 0.08 in 2024. At this time, CVS Health's Asset Turnover is comparatively stable compared to the past year.
Common Stock Shares Outstanding is likely to drop to about 984.2 M in 2024. Net Income Applicable To Common Shares is likely to drop to about 3.7 B in 2024

CVS Health Workforce Comparison

CVS Health Corp is number one stock in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 240,078. CVS Health totals roughly 219,000 in number of employees claiming about 91% of equities under Health Care industry.

CVS Health Profit Margins

The company has Net Profit Margin of 0.02 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.04 %, which entails that for every 100 dollars of revenue, it generated $0.04 of operating income.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.290.1521
Way Up
Very volatile
Operating Profit Margin0.06330.0384
Way Up
Slightly volatile
Pretax Profit Margin0.0530.0312
Way Up
Slightly volatile

CVS Health Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CVS Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on CVS Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, CVS Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-03-01
0.7143
5
7
 171,148 
 50,608 
2023-12-01
3.2
16
5
 112,898 
 3,572 
2023-06-01
2.875
23
8
 996,712 
 236,161 
2023-03-01
0.5714
4
7
 470,985 
 17,193 
2022-12-01
2.3333
14
6
 155,266 
 467,407 
2022-09-01
0.8
4
5
 133,364 
 112,031 
2022-06-01
1.44
36
25
 700,275 
 650,540 
2022-03-01
0.5313
17
32
 1,871,178 
 482,777 
2021-12-01
1.3846
18
13
 347,504 
 670,012 
2021-09-01
0.5
1
2
 3,000 
 29,205 
2021-06-01
0.8857
31
35
 1,600,670 
 1,161,697 
2021-03-01
0.697
23
33
 1,651,822 
 1,487,387 
2020-12-01
2.5
15
6
 79,237 
 69,715 
2020-06-01
2.0
42
21
 3,987,010 
 141,679 
2020-03-01
0.5185
14
27
 712,485 
 897,854 
2019-12-01
3.0
18
6
 52,876 
 152,907 
2019-09-01
0.5
2
4
 26,555 
 52,388 
2019-06-01
1.8333
33
18
 2,521,147 
 321,502 
2019-03-01
1.1364
25
22
 668,086 
 1,092,834 
2018-12-01
1.0526
40
38
 1,946,312 
 765,120 
2018-09-01
0.5
2
4
 17,737 
 39,612 
2018-06-01
0.6774
21
31
 1,173,229 
 252,619 
2018-03-01
0.3478
8
23
 58,231 
 387,007 
2017-12-01
4.0
12
3
 42,313 
 70,539 
2017-09-01
0.4
6
15
 564,683 
 1,233,831 
2017-06-01
1.3438
43
32
 1,711,884 
 691,548 
2017-03-01
0.7407
20
27
 458,935 
 599,867 
2016-06-01
1.6
40
25
 1,103,446 
 295,380 
2016-03-01
1.2
18
15
 312,789 
 296,769 
2015-12-01
3.0
12
4
 37,554 
 47,981 
2015-09-01
0.6154
8
13
 123,229 
 111,799 
2015-06-01
1.4074
38
27
 875,336 
 248,042 
2015-03-01
1.2222
22
18
 843,065 
 1,356,034 
2014-12-01
1.6667
15
9
 225,266 
 126,929 
2014-09-01
0.4615
6
13
 229,632 
 415,448 
2014-06-01
2.1053
40
19
 1,082,236 
 170,764 
2014-03-01
0.7143
10
14
 478,950 
 722,350 
2013-12-01
3.3333
10
3
 50,739 
 86,028 
2013-09-01
0.5
1
2
 562.00 
 1,690 
2013-06-01
2.0909
23
11
 876,744 
 257,397 
2013-03-01
0.8889
8
9
 90,543 
 42,402 
2012-12-01
4.0
8
2
 20,616 
 98,555 
2012-09-01
0.9167
11
12
 516,632 
 543,314 
2012-06-01
2.3333
21
9
 896,254 
 204,894 
2012-03-01
0.9167
11
12
 254,707 
 327,204 
2011-12-01
2.0
14
7
 154,485 
 202,626 
2011-09-01
0.4
2
5
 53,334 
 113,775 
2011-06-01
2.8889
26
9
 987,728 
 457,481 
2011-03-01
0.6667
10
15
 120,564 
 214,926 
2010-12-01
1.3333
12
9
 275,366 
 448,122 
2010-06-01
5.0
25
5
 685,087 
 22,230 
2010-03-01
0.2963
8
27
 227,549 
 381,138 
2009-12-01
1.8571
13
7
 275,368 
 446,846 
2009-09-01
0.375
3
8
 300,000 
 621,337 
2009-06-01
1.8235
31
17
 1,324,976 
 946,902 
2009-03-01
0.8
4
5
 42,711 
 7,255 
2008-12-01
15.0
15
1
 279,730 
 0.00 
2008-06-01
4.1429
29
7
 1,040,190 
 348,095 
2008-03-01
1.3478
31
23
 537,680 
 1,018,325 
2007-12-01
3.2857
23
7
 123,881 
 234,288 
2007-09-01
1.05
21
20
 1,762,952 
 3,568,388 
2007-06-01
1.5172
44
29
 1,811,751 
 2,303,110 
2007-03-01
25.6667
77
3
 14,209,304 
 323,838 
2006-12-01
10.0
20
2
 209,730 
 332,406 
2006-09-01
4.5
9
2
 444.00 
 0.00 
2006-03-01
17.0
17
1
 26,361 
 48,000 
2005-09-01
1.5714
11
7
 183,352 
 336,096 
2005-06-01
2.25
9
4
 41,405 
 68,382 
2005-03-01
3.2857
23
7
 285,904 
 321,604 
2004-12-01
5.0
5
1
 1,851 
 650.00 
2004-09-01
5.0
5
1
 194.00 
 0.00 
2004-06-01
1.1667
7
6
 107,469 
 148,986 
2004-03-01
1.4286
10
7
 199,393 
 34,000 
2003-12-01
0.7
7
10
 96,158 
 182,162 

CVS Health Notable Stakeholders

A CVS Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CVS Health often face trade-offs trying to please all of them. CVS Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CVS Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Vijay PatelSenior CoFounderProfile
Karen LynchPresident, Chief Executive Officer, DirectorProfile
Larry MerloPresident, Chief Executive Officer, DirectorProfile
David DormanIndependent Chairman of the BoardProfile
J JoynerExecutive Vice PresidentProfile
Shawn GuertinChief Financial Officer, Executive Vice PresidentProfile
Kevin HouricanExecutive Vice President, President of CVS PharmacyProfile
Stephen GoldSenior Vice President CIOProfile
Joshua FlumExecutive Vice President, Chief Strategy and Business Development OfficerProfile
Troyen BrennanExecutive Vice President Chief Medical OfficerProfile
Prem ShahExecutive Vice President, Chief Pharmacy Officer and Co-President of RetailProfile
Thomas MoriartyExecutive Vice President, General Counsel, Chief Policy and External Affairs OfficerProfile
Per LofbergExecutive Vice PresidentProfile
David JoynerExecutive Vice PresidentProfile
Jonathan RobertsChief Operating Officer, Executive Vice PresidentProfile
Andrew SussmanSenior Vice President Associate Chief Medical OfficerProfile
Robert KraftExecutive Vice PresidentProfile
Lisa BisacciaChief Human Resource Officer, Executive Vice PresidentProfile
Helena FoulkesExecutive VP and President of CVS Pharmacy IncProfile
Derica RiceExecutive Vice President, President of CVS CaremarkProfile
James ClarkSenior Vice President - Controller, Chief Accounting OfficerProfile
Eva BorattoChief Financial Officer, Executive Vice PresidentProfile
Michelle PelusoExecutive Vice President, Chief Customer Officer and Co-President of RetailProfile
Thomas CowheyExecutive CFOProfile
David DentonCFO and Executive VPProfile
Richard BrackenIndependent DirectorProfile
Mary SchapiroIndependent DirectorProfile
David BrownIndependent DirectorProfile
William WeldonIndependent DirectorProfile
Edward LudwigIndependent DirectorProfile
Richard SwiftIndependent DirectorProfile
Fernando AguirreIndependent DirectorProfile
NancyAnn DeParleIndependent DirectorProfile
JeanPierre MillonIndependent DirectorProfile
Mark BertoliniIndependent DirectorProfile
Alecia DeCoudreauxIndependent DirectorProfile
Tony WhiteIndependent DirectorProfile
Anne FinucaneIndependent DirectorProfile
Roger FarahIndependent DirectorProfile
Prem PharmDChief VPProfile
Samrat EsqChief VPProfile
Laurence McGrathSenior RelationsProfile
Norman GreveChief OfficerProfile
Larry McGrathSr RelationsProfile
David FalkowskiExecutive OfficerProfile
Alan LotvinExecutive Vice President and Presidentident - CVS CaremarkProfile
Neela MontgomeryExecutive Vice President and President - CVS Pharmacy/RetailProfile
Alan MDEx ServicesProfile
Laurie HavanecChief People Officer, Executive Vice PresidentProfile
C BrownIndependent DirectorProfile
David CEBSExecutive CaremarkProfile
Tilak MandadiData, DigitalProfile
Daniel FinkeExecutive Vice President and Presidentident - Health Care Benefits SegmentProfile

About CVS Health Management Performance

The success or failure of an entity such as CVS Health Corp often depends on how effective the management is. CVS Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CVS management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CVS management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for 2024
Return On Capital Employed 0.08  0.08 
Return On Assets 0.03  0.06 
Return On Equity 0.11  0.12 
The data published in CVS Health's official financial statements usually reflect CVS Health's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of CVS Health Corp. For example, before you start analyzing numbers published by CVS accountants, it's critical to develop an understanding of what CVS Health's liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of CVS Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CVS Health's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in CVS Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CVS Health Corp. Please utilize our Beneish M Score to check the likelihood of CVS Health's management manipulating its earnings.

CVS Health Workforce Analysis

Traditionally, organizations such as CVS Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CVS Health within its industry.

CVS Health Manpower Efficiency

Return on CVS Health Manpower

Revenue Per Employee1.6M
Revenue Per Executive6.8B
Net Income Per Employee38.2K
Net Income Per Executive157.9M
When determining whether CVS Health Corp is a strong investment it is important to analyze CVS Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CVS Health's future performance. For an informed investment choice regarding CVS Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for CVS Stock analysis

When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Fundamental Analysis
View fundamental data based on most recent published financial statements
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
CEOs Directory
Screen CEOs from public companies around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Is CVS Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CVS Health. If investors know CVS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CVS Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.10)
Dividend Share
2.42
Earnings Share
6.47
Revenue Per Share
277.528
Quarterly Revenue Growth
0.12
The market value of CVS Health Corp is measured differently than its book value, which is the value of CVS that is recorded on the company's balance sheet. Investors also form their own opinion of CVS Health's value that differs from its market value or its book value, called intrinsic value, which is CVS Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CVS Health's market value can be influenced by many factors that don't directly affect CVS Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CVS Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if CVS Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CVS Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.